Evidence map›Paper›PMID 24030827›Full record

ArticleThe Journal of biological chemistry2013

The role of nonconserved residues of Archaeoglobus fulgidus ferritin on its unique structure and biophysical properties.

Barindra Sana, Eric Johnson, Pierre Le Magueres, Angela Criswell, Duilio Cascio, Sierin Lim

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Chemical reviews · 2026
    Review
  4. Review
  5. Cellular Uptake of Phase-Separating Peptide Coacervates.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  6. Article
  7. Unveiling the stochastic nature of human heteropolymer ferritin self-assembly mechanism.Protein science : a publication of the Protein Society · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Ferritin Nanocages for Protein Delivery to Tumor Cells.Molecules (Basel, Switzerland) · 2020
    Review
  14. Article
  15. Review
  16. Magnetoferritin: Process, Prospects, and Their Biomedical Applications.International journal of molecular sciences · 2019
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Barindra SanaFrom the School of Chemical & Biomedical Engineering, Division of Bioengineering, Nanyang Technological University, Singapore 637457.
Eric Johnsonthe Howard Hughes Medical Institute, Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena, California 91125.
Pierre Le MagueresRigaku Americas, The Woodlands, Texas 77381-5209.
Angela CriswellRigaku Americas, The Woodlands, Texas 77381-5209.
Duilio CascioUCLA-Department of Energy, Institute for Genomics and Proteomics, Los Angeles, California 90095-1570. Electronic address: cascio@mbi.ucla.edu.
Sierin LimFrom the School of Chemical & Biomedical Engineering, Division of Bioengineering, Nanyang Technological University, Singapore 637457,. Electronic address: slim@ntu.sg.
Rigaku (United States) · USCalifornia Institute of Technology · US

Funding

Y-FAMILY POLYMERASES AND CO-FACTORS IN TRANSLESION REPLICATIONP41RR015301 · NCRR · CORNELL UNIVERSITY ITHACA · PI RAO, ANJANA · 2001 to 2011
$28.2M
Overall EvaluationP41GM103403 · NIGMS · CORNELL UNIVERSITY · PI EALICK, STEVEN E · 2012 to 2017
$14.3M
NCRR NIH HHS 5P41RR015301-10NCRR NIH HHS P41 RR015301NIGMS NIH HHS 8 P41 GM103403-10NIGMS NIH HHS P41 GM103403
6 · The paper itself

Abstract

Archaeoglobus fulgidus ferritin (AfFtn) is the only tetracosameric ferritin known to form a tetrahedral cage, a structure that remains unique in structural biology. As a result of the tetrahedral (2-3) symmetry, four openings (∼45 Å in diameter) are formed in the cage. This open tetrahedral assembly contradicts the paradigm of a typical ferritin cage: a closed assembly having octahedral (4-3-2) symmetry. To investigate the molecular mechanism affecting this atypical assembly, amino acid residues Lys-150 and Arg-151 were replaced by alanine. The data presented here shed light on the role that these residues play in shaping the unique structural features and biophysical properties of the AfFtn. The x-ray crystal structure of the K150A/R151A mutant, solved at 2.1 Å resolution, indicates that replacement of these key residues flips a "symmetry switch." The engineered molecule no longer assembles with tetrahedral symmetry but forms a typical closed octahedral ferritin cage. Small angle x-ray scattering reveals that the overall shape and size of AfFtn and AfFtn-AA in solution are consistent with those observed in their respective crystal structures. Iron binding and release kinetics of the AfFtn and AfFtn-AA were investigated to assess the contribution of cage openings to the kinetics of iron oxidation, mineralization, or reductive iron release. Identical iron binding kinetics for AfFtn and AfFtn-AA suggest that Fe(2+) ions do not utilize the triangular pores for access to the catalytic site. In contrast, relatively slow reductive iron release was observed for the closed AfFtn-AA, demonstrating involvement of the large pores in the pathway for iron release.

Indexed as

Amino Acid SubstitutionArchaeal ProteinsArchaeoglobus fulgidusCrystallography, X-RayFerritinsIronProtein BindingProtein Structure, QuaternaryStructure-Activity RelationshipArchaeal ProteinsFerritinsIronArchaeaArchaeoglobus fulgidusEnzyme KineticsFerritinMutantProtein EngineeringProtein Nanocage

Identifiers

PMID24030827
PMCPMC3820901
OpenAlexW2049660039

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.